Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

BioFreedom stent approved in Europe

BioFreedom, a polymer-free drug-coated stent, has received CE Mark approval in Europe.

Carotid stenting appears safe in high-risk patients

There was no evidence that the presence of a contralateral carotid artery occlusion was associated with an increased risk of inhospital death, nonfatal MI or nonfatal stroke in patients undergoing elective carotid artery stenting, based on inhospital outcomes in the CARE Registry.

FDA green-lights three diabetes drugs

The FDA approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets and Oseni (alogliptin and pioglitazone) tablets.

Canadian survey places Riata electrical failures at 4.6%

A survey of two Riata lead models under advisory in Canada found that 4.6 percent of the leads had confirmed or suspected electrical failure. HeartRhythm published the results online Jan. 21.

Left radial access may reduce operator’s radiation exposure

The radiation dose absorbed by operators was significantly lower in physicians who performed radial coronary interventions via the left artery compared with physicians who used the right artery. That was the finding of a randomized trial published online Jan. 23 in the Heart.

ReCor's updated renal denervation system OK’d in Europe

ReCor Medical's updated PARADISE (Percutaneous Renal Denervation) system has received CE Mark in Europe for treating resistant high blood pressure.

Drug-eluting balloons may be more effective than DES for restenosis

In a meta-analysis of five recent trials, researchers found that treating in-stent restenosis with drug-eluting balloons (DEB) reduced the risk of major adverse cardiac events when compared with plain balloon angioplasty or restenting with a Taxus Liberte drug-eluting stent (DES). The results were published online Jan. 18 in Heart.

Medtronic obtains CE Mark for vascular stent

Medtronic has received CE Mark and initiated an international launch of its Complete SE (self-expanding) vascular stent for use in the lower extremities, specifically, the superficial femoral arteries and proximal popliteal arteries.

Displaying 8385 - 8392 of 10761

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.